PathogenDx develops pathogen detection tests for cannabis, life sciences and food safety, including a 100-target detection array.
Founded in 2015 and based in Scottsdale, US, PathogenDx sells pathogen testing products, including the D³ array that identifies up to 100 targets at once. Customers include laboratories, food makers, agriculture and cannabis businesses in the US, Canada and select international markets. Milan Patel is CEO. The company raised USD 7.5 mn in total, most recently in a Series B round on September 30, 2019 led by Entourage Effect Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in